NIH-funded research R01 grant

How bile and gut environment affect Shigella’s harmful tactics

Official title: Mechanistic determination of host environmental impacts on Shigella virulence

Funded at Utah State University · NIH-11347119 · Data updated 2026-11-12

A researcher is studying how the environment inside the gut, especially bile, changes how Shigella bacteria cause disease in people, which could lead to better treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUtah State University
NIH-funded
Lab location1 site (Logan, United States)
Project startJune 22, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$601,319
NIH project number1R01AI198559-01
Project IDNIH-11347119 on NIH RePORTER

Who could benefit from this research

Could help

Not a patient-facing trial yet; results may inform future diagnostics or treatments for people at risk of Shigella infection.

Less likely to help

Direct patient benefit is not guaranteed during this basic science project during its early phases.

What this research studies

This project looks at how Shigella uses its type three secretion system to inject harmful proteins into human cells and how gut conditions like bile influence this process. By studying the interaction between bile salts and the T3SS components, researchers aim to uncover what makes Shigella so infectious. The findings could point to new ways to prevent or treat severe dysentery in patients, especially in children. The work involves lab studies that simulate human gut conditions and analyze the bacterial response to those conditions.

Why it matters

Potential benefit: If successful, the research could reveal targets to block Shigella infection or reduce its severity, guiding new therapies or preventive strategies.

How similar studies have gone: Previous work shows T3SS interactions with bile influence Shigella virulence, supporting a plausible impact but with ongoing questions.

Where this research is happening

  • Utah State University
    Logan, United States
    Active

Researchers

  • Principal investigator: Dickenson, Nicholas E — Utah State University
  • Study coordinator: Dickenson, Nicholas E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.